A clinical syndrome combining hypertension and hypokalemic alkalosis led to the diagnosis of primary hyperaldosteronism, caused by a right-sided, 2 cm large, apparently benign aldosterone-producing adenoma. The adrenal tumor was completely resected by laparoscopic adrenalectomy. Six months after surgery, the patient exhibited a severe relapse of hyperaldosteronism. Extensive peritoneal metastases of a mixed aldosterone- and cortisol-secreting adrenocortical carcinoma were found at abdominal laparotomy. In the light of this case report, we discuss the possibility that laparoscopic resection of adrenocortical tumors might contribute to their subsequent peritoneal dissemination.

Keywords:
Carcinoma, adrenocortical, Hyperaldosteronism, Metastases, peritoneal, Adrenalectomy, laparoscopic
1.
Müller J: Adrenocortical tumours: Clinical and diagnostic findings. Cancer Res 1990;118:106–112.
2.
Slee PH, Schaberg A, Van Brummelen P: Carcinoma of the adrenal cortex causing primary hyperaldosteronism, a case report and review of the literature. Cancer 1983;51:2341–2345.
3.
Icard P, Chapuis Y, Andreassian B, Bernard A, Proye C: Adrenocortical carcinoma in surgically treated patients: A retrospective study on 156 cases by the French Association of Endocrine Surgery. Surgery 1992;112:972–980.
4.
Boscaro M, Fallo F, Barzon L, Daniele O, Sonino N: Adrenocortical carcinoma: Epidemiology and natural history. Minerva Endocrinol 1995;20:89–94.
5.
Henley DJ, van Heerden JA, Grant CS, Carney JA, Carpenter PC: Adrenal cortical carcinoma: A continuing challenge. Surgery 1983;94:926.
6.
Ikeda DM, Francis IR, Glazer GM, Amendola MA, Gross MD, Aisen AM: The detection of adrenal tumours and hyperplasia in patients with primary hyperaldosteronism: Comparison of scintigraphy, CT, and MR imaging. Am J Radiol 1989;153:301–306.
7.
Mathew G, Watson D, Rofe A, Ellis T, Jamieson G: Adverse impact of pneumoperitoneum on intraperitoneal implantation and growth of tumour cell suspension in an experimental model. Aust NZ J Surg 1997;67:289–292.
8.
Påhlman L: The problem of port-site metastases after laparoscopic cancer surgery. Ann Intern Med 1997;29:477–481.
9.
Targarona EM, Martinez J, Nadal A, Balagué C, Cardesa A, Pascual S, Trias M: Cancer dissemination during laparoscopic surgery: Tubes, gas and cells. World J Surg 1998;22:55–61.
10.
Walmsley D, McIntyre R, Sawers HA, Shaw JA, Webster J, Krukowski S, Bevan JS: Laparoscopic trans-peritoneal adrenalectomy: A preliminary report of 14 adrenalectomies. Clin Endocrinol 1996;45:141–145.
11.
Chapuis Y, Maignien B, Abboud B: Surrénalectomie sous coelioscopie. Expérience de 25 interventions. Presse Méd 1995;24:845–848.
12.
Martinez J, Targarona EM, Balagué C, Pera M, Trias M: Port-site metastasis. An unresolved problem in laparoscopic surgery. A review. Int Surg 1995;80:315–321.
13.
Höfle G, Gasser RW, Lhotta K, Janetschek G, Kreczy A, Finkenstedt G: Adrenocortical carcinoma evolving after diagnosis of preclinical Cushing’s syndrome in an adrenal incidentaloma. Horm Res 1998;50:237–242.
14.
Luton JP, Cerda S, Billaud L, Thomas G, Guillaume B, Bertagna X, Laudat MH, Louvel A, Chapuis Y, Blondeau P, Bonnin A, Bricarre H: Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 1990;322:1195–1199.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.